A significant advance in cancer investigation is arising with the use of VHH fragments to re-engage damaged p53. This essential malignant protector protein is frequently lost in various kinds of cancer, resulting https://bookmarklinx.com/story22011763/mini-antibodies-reactivate-tumor-suppressor-p53-a-potential-hope-for-malignant-treatment